RBC Capital Maintains Sector Perform on Pfizer, Raises Price Target to $28
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice TargetHot
RBC Capital analyst Trung Huynh maintains Pfizer (NYSE:PFE) with a Sector Perform and raises the price target from $25 to $28.
RBC Capital analyst Trung Huynh maintains Pfizer (NYSE:PFE) with a Sector Perform and raises the price target from $25 to $28.